pUC vectors capable of conferring neomycin resistance to eukaryotic cells
نویسندگان
چکیده
منابع مشابه
Genetic diseases conferring resistance to infectious diseases
Genetic diseases conferring resistance to infectious diseases Isabelle C. Withrock , Stephen J. Anderson , Matthew A. Jefferson , Garrett R. McCormack , Gregory S.A. Mlynarczyk , Aron Nakama , Jennifer K. Lange , Carrie A. Berg , Sreemoyee Acharya , Matthew L. Stock , Melissa S. Lind , K.C. Luna , Naveen C. Kondru , Sireesha Manne , Bhavika B. Patel , Bierlein M. de la Rosa , Kuei-Pin Huang , S...
متن کاملConjugative plasmid conferring resistance to olaquindox.
A conjugative plasmid, pOLA52, conferring resistance to the antibiotic growth promoter olaquindox has been isolated from Escherichia coli from swine manure. It also confers resistance to ampicillin and chloramphenicol and has a high frequency of transfer between strains of E. coli. Plasmid-borne olaquindox resistance has not been demonstrated before.
متن کاملStability of neomycin resistance in Staphylococcus aureus.
A strain of Staphylococcus aureus isolated from the skin of a subject with eczema showed a loss in resistance to neomycin and tetracycline after treatment with neomycin was stopped. Seven out of 22 strains of neomycin-resistant Staph. aureus showed a loss in resistance to neomycin and streptomycin after storage in nutrient broth for 14 days at room temperature, and it seems probable that resist...
متن کاملExpression of Influenza Heamagglutinin Globular Head in Different Eukaryotic Cells
Background and Aims: Influenza (flu) is a respiratory infection in mammals and birds. It is caused by an RNA virus in the family Orthomyxoviridae. The virus is divided into three main types. Influenza virus type A is found in a wide variety of bird and mammal species and can undergo major shifts in immunological properties. Hemagglutinin (HA) is an important influenza virus surface antigen that...
متن کاملA mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase II.
Fluoroquinolones are broad-spectrum antimicrobial agents that target type II topoisomerases. Many fluoroquinolones are highly specific for bacterial type II topoisomerases and act against both DNA gyrase and topoisomerase IV. In Escherichia coli, mutations causing quinolone resistance are often found in the gene that encodes the A subunit of DNA gyrase. One common site for resistance-conferring...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nucleic Acids Research
سال: 1988
ISSN: 0305-1048,1362-4962
DOI: 10.1093/nar/16.15.7736